Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the use of an oral dose of Terbutaline or a 20% basal
reduction will be able to prevent nocturnal hypoglycemia after an afternoon exercise session.
This is a randomized three period cross-over study including treatment with Terbutaline, a
20% basal reduction for six hours, or no treatment (control).